Rare and intractable fibrodysplasia ossificans progressiva shows different PBMC phenotype possibly modulated by ascorbic acid and propranolol treatment.
FOP
FOPCON
gene expression modulation
peripheral blood mononuclear cells
Journal
Intractable & rare diseases research
ISSN: 2186-3644
Titre abrégé: Intractable Rare Dis Res
Pays: Japan
ID NLM: 101586847
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
15
01
2021
revised:
02
04
2021
accepted:
29
04
2021
entrez:
1
9
2021
pubmed:
2
9
2021
medline:
2
9
2021
Statut:
ppublish
Résumé
Fibrodysplasia Ossificans Progressiva (FOP) is a rare congenital intractable disease associated with a mutation in
Identifiants
pubmed: 34466340
doi: 10.5582/irdr.2021.01012
pmc: PMC8397826
doi:
Types de publication
Journal Article
Langues
eng
Pagination
179-189Informations de copyright
2021, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Bone. 2018 Apr;109:232-240
pubmed: 29097342
Shock. 2003 Feb;19(2):108-12
pubmed: 12578116
Genes Nutr. 2014 May;9(3):390
pubmed: 24604612
J Clin Invest. 2017 Sep 1;127(9):3339-3352
pubmed: 28758906
Nat Genet. 2006 May;38(5):525-7
pubmed: 16642017
PLoS One. 2013;8(3):e60021
pubmed: 23555867
J Bone Miner Res. 2008 Mar;23(3):305-13
pubmed: 17967130
Cytometry B Clin Cytom. 2018 Jul;94(4):613-622
pubmed: 28985649
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Biol Chem. 2010 Feb 12;285(7):4319-27
pubmed: 19946124
Int J Clin Exp Pathol. 2013 Dec 15;7(1):48-55
pubmed: 24427325
Expert Opin Orphan Drugs. 2017;5(4):291-294
pubmed: 29177121
J Intern Med. 2009 Jun;265(6):663-79
pubmed: 19493060
Exp Cell Res. 1997 Sep 15;235(2):362-9
pubmed: 9299160
Biochim Biophys Acta. 2002 Jan 15;1569(1-3):1-9
pubmed: 11853951
Tex Heart Inst J. 2007;34(3):268-74
pubmed: 17948074
J Invest Dermatol. 2001 Jun;116(6):853-9
pubmed: 11407971
Physiol Rev. 2018 Jan 1;98(1):505-553
pubmed: 29351514
Cent Eur J Immunol. 2015;40(3):373-9
pubmed: 26648784
Am J Pathol. 2007 Feb;170(2):620-32
pubmed: 17255330
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9
pubmed: 16157892
Gene. 2019 Jul 30;707:151-171
pubmed: 31075413
Crit Rev Eukaryot Gene Expr. 2010;20(4):313-24
pubmed: 21395504
Br J Clin Pharmacol. 2019 Jun;85(6):1180-1187
pubmed: 30501012
Calcif Tissue Int. 1997 Apr;60(4):394
pubmed: 9075640
J Biol Chem. 1996 Jun 7;271(23):13900-7
pubmed: 8662814
J Bone Miner Res. 2012 Jun;27(6):1252-62
pubmed: 22407956
Nat Med. 2004 Apr;10(4):396-401
pubmed: 15034573
J Clin Invest. 2007 Jun;117(6):1616-26
pubmed: 17549257
J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):79-110
pubmed: 12503609
Muscle Nerve. 2019 Apr;59(4):501-508
pubmed: 30623463
Calcif Tissue Int. 2014 Jun;94(6):621-31
pubmed: 24626604
Microsc Res Tech. 2002 Jul 15;58(2):77-84
pubmed: 12203706
J Interferon Cytokine Res. 2005 Jul;25(7):384-94
pubmed: 16022583
Sci Rep. 2017 Mar 28;7:45597
pubmed: 28349965
Bone. 2016 Mar;84:169-180
pubmed: 26769004
Cell Signal. 2020 Dec;76:109813
pubmed: 33080316
Development. 2016 Nov 1;143(21):3933-3943
pubmed: 27621060
Intractable Rare Dis Res. 2019 Feb;8(1):24-28
pubmed: 30881854
Oral Dis. 2016 Sep;22(6):463-93
pubmed: 26808119
JCI Insight. 2018 Nov 15;3(22):
pubmed: 30429363
Curr Genomics. 2010 Mar;11(1):52-7
pubmed: 20808524
Dev Cell. 2004 Mar;6(3):423-35
pubmed: 15030764
Angiogenesis. 2003;6(4):259-69
pubmed: 15166494
J Trace Elem Med Biol. 2017 Jan;39:186-192
pubmed: 27908413
Immunol Rev. 2012 Jul;248(1):188-204
pubmed: 22725962
Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2:437-48
pubmed: 23858627
Biochim Biophys Acta. 2007 Jan;1772(1):32-9
pubmed: 17008068
Front Pharmacol. 2015 Aug 13;6:171
pubmed: 26321956
Eur J Clin Pharmacol. 1995;48(3-4):295-7
pubmed: 7589058
Dev Biol. 2015 Apr 15;400(2):202-9
pubmed: 25722188